Search

Your search keyword '"Michael Lazarus"' showing total 380 results

Search Constraints

Start Over You searched for: Author "Michael Lazarus" Remove constraint Author: "Michael Lazarus"
380 results on '"Michael Lazarus"'

Search Results

151. Comparison of Hemodialysis Blood Access Flow Rates Using Online Measurement of Conductivity Dialysance and Ultrasound Dilution

152. Potential Impact of Nutritional Intervention on End-Stage Renal Disease Hospitalization, Death, and Treatment Costs

153. Intensity of Dialysis in Established Acute Renal Failure

154. Dialysis Facility Ownership and Epoetin Dosing in Hemodialysis Patients: A Dialysis Provider’s Perspective

155. CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: The Association between Blood Pressure and Mortality in ESRD-Not Different from the General Population?

157. How genetically engineered systems are helping to define, and in some cases redefine, the neurobiological basis of sleep and wake

158. Neuroanatomy and transgenic technologies

160. The Epidemiology of Systolic Blood Pressure and Death Risk in Hemodialysis Patients

161. The differential role of prostaglandin E2 receptors EP3 and EP4 in regulation of fever

162. UNRESOLVED ISSUES IN DIALYSIS: Dialyzer Best Practice: Single Use or Reuse?

163. Epoetin Alfa Use in Patients With ESRD: An Analysis of Recent US Prescribing Patterns and Hemoglobin Outcomes

164. Structural and Mutational Analysis of Trypanosoma brucei Prostaglandin H2 Reductase Provides Insight into the Catalytic Mechanism of Aldo-ketoreductases

165. Activated Injectable Vitamin D and Hemodialysis Survival

166. Market penetration metrics: tools for additionality assessment?

167. Measurement of dialyzer clearance, dialysis time, and body size: Death risk relationships among patients

168. Species-specific expression of microsomal prostaglandin E synthase-1 and cyclooxygenases in male monkey reproductive organs

169. Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis

170. Baseline recommendations for greenhouse gas mitigation projects in the electric power sector

171. Altérations du sommeil en réponse à la modulation par pharmacogénétique de l’activité des neurones exprimant l’hormone de mélano-concentration

172. Interactions between dialysis-related volume exposures, nutritional surrogates and mortality among ESRD patients

173. Survival of Patients Undergoing Hemodialysis with Paricalcitol or Calcitriol Therapy

174. The association between mental health, physical function, and hemodialysis mortality

175. Effect of Variability in Anemia Management on Hemoglobin Outcomes in ESRD

176. Prostaglandin production from arachidonic acid and evidence for a 9,11-endoperoxide prostaglandin H2 reductase in Leishmania

177. Biotransformations with oxidases and peroxidases for the synthesis of optically active building blocks

178. A Key Role for Old Yellow Enzyme in the Metabolism of Drugs by Trypanosoma cruzi

179. Slow-wave sleep is controlled by a subset of nucleus accumbens core neurons in mice

180. Activation of E-prostanoid 3 receptor in macrophages facilitates cardiac healing after myocardial infarction

181. Sickle trait in African-American hemodialysis patients and higher erythropoiesis-stimulating agent dose

182. Association between prevalent care process measures and facility-specific mortality rates

183. Dominant localization of prostaglandin D receptors on arachnoid trabecular cells in mouse basal forebrain and their involvement in the regulation of non-rapid eye movement sleep

184. Cardiac arrest and sudden death in dialysis units

185. Cleaner generation, free-riders, and environmental integrity: clean development mechanism and the power sector

186. Suspected iron dextran-related adverse drug events in hemodialysis patients

187. Projections of nucleus accumbens adenosine A2A receptor neurons in the mouse brain and their implications in mediating sleep-wake regulation

188. Prealbumin is as important as albumin in the nutritional assessment of hemodialysis patients

189. Comparing the urea reduction ratio and the urea product as outcome-based measures of hemodialysis dose

190. Vintage, nutritional status, and survival in hemodialysis patients

191. Quality-of-life evaluation using Short Form 36: Comparison in hemodialysis and peritoneal dialysis patients

192. Cellular localization of lipocalin-type prostaglandin D synthase (?-trace) in the central nervous system of the adult rat

193. Exploring the reverse J-shaped curve between urea reduction ratio and mortality

194. Associates of mortality among peritoneal dialysis patients with special reference to peritoneal transport rates and solute clearance

196. Recommended criteria for initiating and discontinuing intradialytic parenteral nutrition therapy

197. The Role of Providers in Implementation of the National Kidney Foundation-Dialysis Outcomes Quality Initiative: Fresenius Medical Care North America Perspective

200. EP3 prostaglandin receptors in the median preoptic nucleus are critical for fever responses

Catalog

Books, media, physical & digital resources